Clinical Trial Update: Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating a gene expression signature predicting panitumumab sensitivity in untreated locally advanced squamous cell carcinoma of the h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Neal Ready | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: TERMINATED | Results posted: 2014-08-29